Loading…
Loading…
Sell-side consensus EPS, revenue estimates, YoY growth, forward P/E, and per-year analyst coverage, for any covered stock.
TapClick below to see what's inside, then upgrade to unlock for this and 80,000+ other tickers.
See price against where its own fundamentals say it should trade. The shaded gap is the discount or premium, across five valuation lenses.
TapClick below to see what's inside, then upgrade to unlock for L and 80,000+ other tickers.
See exactly how L's revenue becomes profit: a Sankey that traces revenue (and its reported segments) through gross profit, operating expenses, and net profit, with the year-over-year change on every line.
The same diagram the Chart Builder draws, right on the Summary tab. Upgrade to unlock it for L and 80,000+ other tickers.
Loews Corporation functions as a diversified holding company, with significant business segments spanning insurance, energy infrastructure, hospitality, and manufacturing. Its insurance division delivers commercial property and casualty coverage to clients both within the United States and internationally. This segment offers a comprehensive array of products, including specialized options such as professional and management liability, along with surety and fidelity bonds. Property insurance solutions encompass general property, marine risks, and boiler and machinery protection. For casualty…
Loews Corporation to Release Third Quarter 2026 Results on November 2, 2026PR NewswireNEW YORK, Oct. 13, 2026NEW YORK, Oct. 13, 2026 /PRNewswire/ -- Loews Corpo
NEW YORK, Oct. 13, 2026 /PRNewswire/ -- Loews Corporation (NYSE: L) will report third quarter 2026 financial results on Monday, November 2, 2026. On that date the Company will also post earnings remarks on its website.
Mesoblast Limited (NASDAQ: MESO - Get Free Report)'s stock price crossed below its 50 day moving average during trading on Monday. The stock has a 50 day moving average of $15.78 and traded as low as $14.27. Mesoblast shares last traded at $14.27, with a volume of 143,761 shares traded. Wall Street Analyst Weigh In Several
Ginkgo Bioworks and Eli Lilly announced a partnership last month focused on AI drug discovery. The stock has skyrocketed since the partnership was announced.
LOEWS CORPORATION ANNOUNCES QUARTERLY DIVIDEND ON COMMON STOCK PR Newswire NEW YORK, Aug. 4, 2026